IOL CHEMICALS & PHARM. | SUN PHARMA | IOL CHEMICALS & PHARM./ SUN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | 39.6 | 34.2% | View Chart |
P/BV | x | 1.5 | 6.4 | 24.2% | View Chart |
Dividend Yield | % | 1.0 | 0.8 | 130.4% |
IOL CHEMICALS & PHARM. SUN PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SUN PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ SUN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 1,072 | 50.1% | |
Low | Rs | 272 | 790 | 34.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 182.9 | 206.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | 35.7 | 66.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 46.2 | 68.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 11.50 | 34.8% | |
Avg Dividend yield | % | 1.0 | 1.2 | 80.1% | |
Book value per share (Unadj.) | Rs | 256.8 | 233.4 | 110.0% | |
Shares outstanding (eoy) | m | 58.71 | 2,399.34 | 2.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 5.1 | 21.0% | |
Avg P/E ratio | x | 17.1 | 26.1 | 65.4% | |
P/CF ratio (eoy) | x | 12.8 | 20.1 | 63.6% | |
Price / Book Value ratio | x | 1.6 | 4.0 | 39.5% | |
Dividend payout | % | 16.9 | 32.2 | 52.4% | |
Avg Mkt Cap | Rs m | 23,743 | 2,233,361 | 1.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 82,960 | 2.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 438,857 | 5.1% | |
Other income | Rs m | 256 | 8,199 | 3.1% | |
Total revenues | Rs m | 22,427 | 447,055 | 5.0% | |
Gross profit | Rs m | 2,257 | 112,900 | 2.0% | |
Depreciation | Rs m | 462 | 25,294 | 1.8% | |
Interest | Rs m | 165 | 1,720 | 9.6% | |
Profit before tax | Rs m | 1,887 | 94,084 | 2.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 8,476 | 5.8% | |
Profit after tax | Rs m | 1,391 | 85,608 | 1.6% | |
Gross profit margin | % | 10.2 | 25.7 | 39.6% | |
Effective tax rate | % | 26.2 | 9.0 | 291.3% | |
Net profit margin | % | 6.3 | 19.5 | 32.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 398,619 | 2.4% | |
Current liabilities | Rs m | 5,025 | 199,064 | 2.5% | |
Net working cap to sales | % | 20.9 | 45.5 | 46.0% | |
Current ratio | x | 1.9 | 2.0 | 96.1% | |
Inventory Days | Days | 43 | 147 | 29.4% | |
Debtors Days | Days | 8 | 95 | 8.7% | |
Net fixed assets | Rs m | 11,017 | 376,960 | 2.9% | |
Share capital | Rs m | 587 | 2,399 | 24.5% | |
"Free" reserves | Rs m | 14,490 | 557,555 | 2.6% | |
Net worth | Rs m | 15,077 | 559,954 | 2.7% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 775,794 | 2.7% | |
Interest coverage | x | 12.5 | 55.7 | 22.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.6 | 189.5% | |
Return on assets | % | 7.5 | 11.3 | 66.8% | |
Return on equity | % | 9.2 | 15.3 | 60.4% | |
Return on capital | % | 13.6 | 17.1 | 79.5% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 154,053 | 3.8% | |
Fx outflow | Rs m | 6,052 | 71,511 | 8.5% | |
Net fx | Rs m | -122 | 82,541 | -0.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 49,593 | 2.5% | |
From Investments | Rs m | -1,200 | -79,437 | 1.5% | |
From Financial Activity | Rs m | -41 | 23,761 | -0.2% | |
Net Cashflow | Rs m | -18 | 1,155 | -1.6% |
Indian Promoters | % | 48.2 | 54.5 | 88.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 36.5 | 4.7% | |
FIIs | % | 1.4 | 17.7 | 7.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 45.5 | 113.8% | |
Shareholders | 130,003 | 631,392 | 20.6% | ||
Pledged promoter(s) holding | % | 0.0 | 2.1 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES SUPRIYA LIFESCIENCE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Sun Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.64% | -3.63% | -0.57% |
1-Month | 4.77% | -7.09% | 0.07% |
1-Year | -0.25% | 51.52% | 52.18% |
3-Year CAGR | -13.23% | 32.51% | 14.04% |
5-Year CAGR | 16.12% | 25.93% | 19.13% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Sun Pharma share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Sun Pharma the stake stands at 54.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Sun Pharma.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Sun Pharma.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.